Bio-Rad Laboratories Company Profile (NYSE:BIO)

About Bio-Rad Laboratories

Bio-Rad Laboratories logoBio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company's Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company's Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: BIO
  • CUSIP: 09057220
Key Metrics:
  • Previous Close: $160.02
  • 50 Day Moving Average: $155.22
  • 200 Day Moving Average: $145.52
  • 52-Week Range: $122.03 - $162.51
  • Trailing P/E Ratio: 49.16
  • Foreward P/E Ratio: 47.75
  • P/E Growth: 5.16
  • Market Cap: $4.77B
  • Outstanding Shares: 29,423,000
  • Beta: 0.93
Profitability:
  • Net Margins: 4.79%
  • Return on Equity: 3.86%
  • Return on Assets: 2.59%
Debt:
  • Debt-to-Equity Ratio: 0.17%
  • Current Ratio: 4.40%
  • Quick Ratio: 3.08%
Additional Links:
Companies Related to Bio-Rad Laboratories:

Analyst Ratings

Consensus Ratings for Bio-Rad Laboratories (NYSE:BIO) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $187.00 (15.19% upside)

Analysts' Ratings History for Bio-Rad Laboratories (NYSE:BIO)
Show:
DateFirmActionRatingPrice TargetDetails
9/7/2016Jefferies GroupBoost Price TargetBuy$200.00 -> $225.00View Rating Details
11/4/2015Leerink SwannBoost Price Target$143.00 -> $149.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Bio-Rad Laboratories (NYSE:BIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
8/3/2016Q2$1.13$0.61$497.80 million$516.80 millionViewN/AView Earnings Details
5/5/2016Q1$0.60$0.42$463.90 million$471.20 millionViewN/AView Earnings Details
2/25/2016Q415$1.27$1.68$570.80 million$570.56 millionViewListenView Earnings Details
11/3/2015Q315$0.54$0.59$495.55 million$469.96 millionViewN/AView Earnings Details
8/6/2015Q215$0.78$0.97$494.85 million$506.10 millionViewN/AView Earnings Details
5/5/2015Q115$0.33$0.61$474.60 million$472.80 millionViewN/AView Earnings Details
2/26/2015Q414$1.18$1.34$593.41 million$598.20 millionViewN/AView Earnings Details
11/4/2014Q314$0.86$0.39$525.40 million$530.64 millionViewN/AView Earnings Details
8/5/2014Q214$0.95$1.09$537.58 million$536.80 millionViewN/AView Earnings Details
5/6/2014Q114$0.80$0.23$515.00 million$509.30 millionViewN/AView Earnings Details
2/27/2014Q413$1.42$1.04$586.67 million$602.60 millionViewListenView Earnings Details
11/7/2013Q313$0.91($0.25)$529.02 million$505.10 millionViewListenView Earnings Details
8/6/2013Q2 2013$1.25$1.20$532.60 million$525.30 millionViewListenView Earnings Details
5/7/2013Q1 2013$1.03$0.68$506.34 million$499.70 millionViewN/AView Earnings Details
2/26/2013Q4 2012$1.33$1.65$558.68 million$573.80 millionViewN/AView Earnings Details
11/6/2012Q312$1.14$1.48$507.79 million$498.70 millionViewN/AView Earnings Details
8/7/2012$1.19$1.69ViewN/AView Earnings Details
5/1/2012$1.02$1.09ViewN/AView Earnings Details
2/23/2012$1.67$2.08ViewN/AView Earnings Details
11/1/2011$1.53$1.61ViewN/AView Earnings Details
8/2/2011$1.47$1.41ViewN/AView Earnings Details
5/3/2011$1.32$1.16ViewN/AView Earnings Details
2/24/2011$1.35$2.41ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio-Rad Laboratories (NYSE:BIO)
Current Year EPS Consensus Estimate: $3.10 EPS
Next Year EPS Consensus Estimate: $3.40 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.72$0.85$0.79
Q2 20163$1.01$1.12$1.07
Q3 20162$0.51$0.84$0.68
Q4 20162$1.15$1.55$1.35
Q1 20171$0.72$0.72$0.72
Q2 20171$1.04$1.04$1.04
Q3 20171$0.73$0.73$0.73
Q4 20171$0.91$0.91$0.91
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Bio-Rad Laboratories (NYSE:BIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bio-Rad Laboratories (NYSE:BIO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Bio-Rad Laboratories (NYSE:BIO)
DateHeadline
prnewswire.com logoReportLinker Review : Antinuclear Antibody Test Market by Product ... - PR Newswire (press release) (NYSE:BIO)
www.prnewswire.com - September 27 at 8:26 AM
prnewswire.com logoNorth America Molecular Diagnostics Market Analysis by Product, by ... - PR Newswire (press release) (NYSE:BIO)
www.prnewswire.com - September 27 at 8:26 AM
investornewswire.com logoShares Of Bio-Rad Laboratories, Inc. (NYSE:BIO) Expected To Hit $225 - Investor Newswire (NYSE:BIO)
www.investornewswire.com - September 24 at 3:45 PM
einnews.com logoFood Traceability Market expected to reach $19.7 billion with 12.2% CAGR to 2021 (NYSE:BIO)
brazilbusiness.einnews.com - September 23 at 3:18 PM
newsmaker.com.au logoFood Traceability Global Market 2016 Analysis and Forecast to 2021 (NYSE:BIO)
www.newsmaker.com.au - September 23 at 8:56 AM
News IconBiotech news that matter for investors: Illumina Inc. (NASDAQ:ILMN), Vertex Pharmaceuticals Incorporated (NASDAQ ... - The Voice Registrar (NYSE:BIO)
voiceregistrar.com - September 22 at 4:00 PM
einnews.com logoGlobal Transplant diagnostics Market Size, Share, Strategy, Research Forecast to 2027 (NYSE:BIO)
www.einnews.com - September 21 at 3:17 PM
finance.yahoo.com logoIn Vitro Toxicology Testing Market by Product, Type, Toxicity Endpoints & Tests, Technology, Method, Industry ... - Yahoo Finance (NYSE:BIO)
finance.yahoo.com - September 20 at 9:06 AM
News IconDeep Study on DNA Diagnostics Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 | Hexa Research (NYSE:BIO)
www.usfinancialnewstoday.com - September 19 at 8:37 AM
News IconWhat is end result of Analyst Consensus? Bio-Rad Laboratories, Inc. (NYSE:BIO) , Lumos Networks Corp. (NASDAQ ... - Wall Street Times (press release) (NYSE:BIO)
www.wallstreetnews24.com - September 16 at 3:47 PM
News IconOrbis Research: Global Membrane Filtration Devices Industry Report 2016-2021 (NYSE:BIO)
www.medgadget.com - September 16 at 12:21 PM
News IconGlobal HIV-AIDS Testing Market : Historical, current and projected industry size 2020 (NYSE:BIO)
www.medgadget.com - September 15 at 3:38 PM
News IconIn Fight With GC, Bio-Rad Adds Quinn Emanuel to Legal Team (NYSE:BIO)
www.therecorder.com - September 15 at 3:38 PM
News IconIn Fight With GC, Bio-Rad Adds Quinn Emanuel to Legal Team - The Recorder (NYSE:BIO)
www.therecorder.com - September 15 at 12:44 PM
News IconShares Holding Above Moving Averages: Bio-Rad Laboratories, Inc ... - Post News (NYSE:BIO)
www.kentuckypostnews.com - September 14 at 9:01 PM
News IconGlobal Biomarkers Market size and forecast By 2020 (NYSE:BIO)
www.medgadget.com - September 14 at 5:53 AM
globenewswire.com logoMolecular Diagnostics Market To Reach $17.9 Billion By 2024 ... - GlobeNewswire (press release) (NYSE:BIO)
globenewswire.com - September 13 at 8:43 AM
News IconStock Up Over the Past Five Trading Sessions: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Post News (NYSE:BIO)
www.kentuckypostnews.com - September 13 at 8:43 AM
einnews.com logoIn-Vitro Toxicology Testing Market to Reach $27.38 billion with 14.10% CAGR Forecast to 2022 (NYSE:BIO)
world.einnews.com - September 12 at 3:45 PM
einnews.com logoIn-Vitro Toxicology Testing Market to Reach $27.38 billion with 14.10% CAGR Forecast to 2022 (NYSE:BIO)
world.einnews.com - September 12 at 3:45 PM
News IconUnited States Cytokine Testing Market Report 2016 is released (NYSE:BIO)
www.idatainsights.com - September 12 at 3:45 PM
News IconStock on the Rise Over the Last Half Year: Bio-Rad Laboratories, Inc ... - Post News (NYSE:BIO)
www.kentuckypostnews.com - September 12 at 8:38 AM
News IconBiochip Market To Witness Growth Owing To Increased Usage In Biotechnology And Pharmaceutical Companies Till 2024: Grand View Research, Inc. (NYSE:BIO)
www.abnewswire.com - September 10 at 8:34 AM
News IconGlobal Drug of Abuse Testing Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Produ... (NYSE:BIO)
www.advfn.com - September 9 at 3:45 PM
einnews.com logoIn Vitro Diagnostics Market 2016 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast to 2022 (NYSE:BIO)
brazilbusiness.einnews.com - September 9 at 3:45 PM
News IconDiscover the in-vitro diagnostics market analysis by size, share, growth, and trends 2016 and forecast to 2020 (NYSE:BIO)
www.whatech.com - September 9 at 8:41 AM
News IconGlobal PCR Reagent Market Research Report 2016 is released (NYSE:BIO)
www.idatainsights.com - September 8 at 3:45 PM
capitalcube.com logoETF’s with exposure to Bio-Rad Laboratories, Inc. : September 8, 2016 (NYSE:BIO)
www.capitalcube.com - September 8 at 3:45 PM
News IconStock Sliding Down Over the Last Month: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Post News (NYSE:BIO)
www.kentuckypostnews.com - September 7 at 8:57 PM
News IconIn vitro diagnostics market is projected to reach $75.1 billion by 2020 according to new research report (NYSE:BIO)
www.whatech.com - September 7 at 3:51 PM
News IconMolecular Cytogenetics Market To Be Driven By Rising Incidence Of Congenital & Genetic Disorders Till 2022: Grand View Research, Inc. (NYSE:BIO)
www.abnewswire.com - September 7 at 3:51 PM
News IconRubella Diagnostic Testing Market is categorized on the basis of diagnostic testing techniques over the forecast period (NYSE:BIO)
globalmarketresearchinsight.wordpress.com - September 7 at 12:33 PM
News IconGlobal Gene Vector Sales Industry Forecast to 2021 with Key Companies Profile, Supply, Demand, Cost Structure, and SWOT Analysis (NYSE:BIO)
empowerednews.net - September 6 at 8:40 PM
einnews.com logoBiomarker Technology Market 2016 Global Analysis,Share,Trend,Segmentation and Forecast to 2021 Research Report (NYSE:BIO)
www.einnews.com - September 6 at 8:40 PM
finance.yahoo.com logoPCR Technologies Global market - Forecast to 2022 (NYSE:BIO)
finance.yahoo.com - September 6 at 3:34 PM
News IconMicrofluidics Market Size To Reach $10.0 Billion By 2024: Grand View Research, Inc. (NYSE:BIO)
www.abnewswire.com - September 6 at 8:39 AM
News IconBiomarker technology market 2021 new research study available in new report (NYSE:BIO)
www.whatech.com - September 6 at 8:39 AM
News IconGlobal laboratory reagent sales market forecast to 2021 published by leading research firm (NYSE:BIO)
www.whatech.com - September 5 at 3:45 PM
einnews.com logoBiochips Market 2016 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast to 2022 (NYSE:BIO)
www.einnews.com - September 3 at 8:30 AM
einnews.com logoPolymerase Chain Reaction (PCR) Technologies World Market Segmentation and Major Players Analysis 2022 (NYSE:BIO)
www.einnews.com - September 1 at 3:49 PM
News IconBiomarker Technology Market Value Analysis and Forecast 2016 (NYSE:BIO)
empowerednews.net - August 30 at 3:49 PM
News IconGlobal Biomarker Technology Market Professional Survey Report 2016 (NYSE:BIO)
www.rnrmarketresearch.com - August 30 at 8:13 AM
News IconGlobal Immunohistochemistry Market 2016 Latest Report Available at Orbisresearch.com (NYSE:BIO)
www.medgadget.com - August 30 at 8:13 AM
sbwire.com logoTransplantation Diagnostics Market Is Expected to Reach $2,059.2 Million by 2022; Finds New Report (NYSE:BIO)
www.sbwire.com - August 29 at 4:27 PM
News IconEurope Molecular Diagnostics Market Worth $4.0 Billion By 2024: Grand View Research, Inc. (NYSE:BIO)
www.abnewswire.com - August 26 at 11:55 AM
einnews.com logoGlobal Transplantation Diagnostics Market 2016 Share, Trend, Segmentation and Forecast to 2022 (NYSE:BIO)
world.einnews.com - August 26 at 11:55 AM
einnews.com logoImmunoassay Global Market Segmentation,Application,Technology & Market Analysis Research Report 2022 (NYSE:BIO)
www.einnews.com - August 25 at 9:17 PM
News IconUrinalysis Test Market Regional Analysis, Market Share and Forecast to 2027. (NYSE:BIO)
www.medgadget.com - August 25 at 8:42 AM
finance.yahoo.com logoBiochip Market Size Projected to Reach $25.8 Billion by 2024: Grand View Research, Inc. (NYSE:BIO)
finance.yahoo.com - August 24 at 3:50 PM
einnews.com logoUrinalysis Test Market Development, Market Trend, Segmentation and Forecast to 2027. (NYSE:BIO)
world.einnews.com - August 24 at 3:50 PM

Social

Bio-Rad Laboratories (NYSE:BIO) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff